Nooruddin Shaik. (2023). A Critical Review of Cinqair (Reslizumab) in the Treatment of Severe Asthma Patients. Future Journal of Pharmaceuticals and Health Sciences, 3(2), 126–133. https://doi.org/10.26452/fjphs.v3i2.442